Caroline P. Halverstam

Caroline P. Halverstam, M.D.

Area of research

  • Resident and medical student education; complex medical dermatology

Email

Location

  • Jacobi Medical Center 1400 Pelham Parkway South Building 8 Bronx, NY 10461

Lab of Caroline P. Halverstam

Are You a Patient?



Research Profiles

Professional Interests

Dr. Caroline Halverstam is an associate professor at Albert Einstein College of Medicine and Chief of the Division of Dermatology at Jacobi Medical Center. She did her undergraduate studies at Northwestern University, where she graduated magna cum laude. She received her medical degree from Washington University School of Medicine in St. Louis, Missouri and completed an internship at New York University. She did residency in dermatology at Mt. Sinai Medical Center in New York, where she served as Chief resident during her final year.

She is a board-certified dermatologist and member of the American Academy of Dermatology, New York State Society of Dermatology and Dermatologic Surgery and New York Academy of Medicine, Dermatology division. She serves on the editorial board of the Journal of American Academy of Dermatology Case Reports. 

Dr. Halverstam focuses her career on complex medical dermatology and resident and student education. She is highly competent in treating adults and children for general dermatological conditions, including rashes, acne, rosacea and eczema as well as conducting skin cancer screenings. Dr. Halverstam is also well trained in the treatment of complex dermatological diseases including difficult cases of psoriasis, blistering diseases and auto-immune diseases. 

Selected Publications

Halverstam CP, Mann M, Kim-James H, Heffernan MP. Methotrexate UV RecallWashington University Dermatology Internet Case Report.  May 2005.    

 

Halverstam CP, Zeichner J, Lebwohl M.  Lack of Significant Skeletal Changes After Long-term, Low Dose Retinoid Therapy: A Case Report and Review of the Literature.  J Cutan Med Surg 2006; 10:291-9

 

Halverstam CP.  Practical Management and Monitoring of Psoriasis Patients on Biologic Therapy.  Psoriasis Forum 2007; 13:4-12

 

Halverstam CP, Vachharajani A, Mallory SB.  Cushing Syndrome from Percutaneous Absorption of 1% Hydrocortisone Ointment in Netherton Syndrome.  Pediatr Dermatol 2007; 24:42-45

 

Vidal C, Kapelusznik L, Goldberg M, Halverstam C, Daefler S, Calfee D, Phelps RG. The dermatologic manifestation of swine flu (pandemic (H1N1) 2009 influenza virus).  Arch Dermatol 2010; 146:101-2

 

Halverstam CP, Mercer SE, Harwayne-Gidansky I, Geller L, Phelps RG.  Stiff skin syndrome in a newborn infant.  Int J Dermatol 2013; 52: 993-5

 

Singleton R, Halverstam C. Diagnosis and management of cold urticaria.  Cutis 2016; 97:59-62 

 

Lin A, Nabatian A, Halverstam CP. Discovering Black Soap: A survey on the attitudes and practices of black soap users. J Clin Aesthet Dermatol 2017; 10:18-22

 

Ovits CG, Amin BD, Halverstam C. Acquired Epidermodysplasia Verruciformis and Its Relationship to Immunosuppressive Therapy: Report of a Case and Review of the Literature. J Drugs Dermatol 2017; 16:701-4

 

Blecher Paz K, Halverstam C, Rzepecki AK, McLellan BN. A National Survey of Medical Coding and Billing Training in United States Dermatology Residency Programs J Drugs Dermatol 2018; 17:678-82

 

Soliman YS, Rzepecki AK, Guzman AK, Williams RF, Cohen SR, Ciocon D, Halverstam C. Understanding Perceived Barriers of Minority Medical Students Pursuing a Career in Dermatology. JAMA Dermatol 2019; 155:252-4

 

Nazarian RS, Zheng E, Halverstam CCohen SR, Wolkoff AW. Prolonged Serum Alanine Aminotransferase Elevation Associated with Isotretinoin Administration. Case Reports in Hepatology 2019, Article ID 9270827, 3 pages

Time-series analysis of National Residency Matching Program data for the dermatology match in the United States. Kamath P, Wong L, Stratman S, Halverstam C.J Am Acad Dermatol. 2019; 83: 210-213

Current Status of Dermatologic Education in US Medical Schools. Cahn BA, Harper HE, Halverstam CP, Lipoff JB. JAMA Dermatol 2020; 156:468-470

 

Telogen effluvium: a sequela of COVID-19. Mieczkowska K, Deutsch A, Borok J, Guzman AK, Fruchter R, Patel P, Wind O, McLellan BN, Mann RE, Halverstam CP. Int J Dermatol 2021; 60:122-124